MétaCan
Menu
Back to cohort
Record W4413885454 · doi:10.1093/eurjpc/zwaf539

Heterogeneous cardiovascular effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a causal forest and target trial emulation study

2025· article· en· W4413885454 on OpenAlexfundno aff
Yuichiro Mori, Toshiaki Komura, Motohiko Adomi, Ryuichiro Yagi, Shingo Fukuma, Koji Kawakami, Naoki Kondo, Yusuke Tsugawa, Daisuke Yabe, Motoko Yanagita, Kosuke Inoue

Bibliographic record

VenueEuropean Journal of Preventive Cardiology · 2025
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsnot available
FundersNational Institute on Minority Health and Health DisparitiesJapan Science and Technology AgencyJapan Society for the Promotion of ScienceNational Institutes of HealthEisai CanadaAstraZeneca KKGeneral Insurance Association of JapanNational Institute on AgingKyowa Hakko KirinOMRON CorporationNorges Idrettshøgskole
KeywordsMedicineInternal medicineDiabetes mellitusType 2 diabetesMyocardial infarctionStroke (engine)DiseaseBody mass indexType 2 Diabetes MellitusRelative riskDipeptidyl peptidase-4Confidence intervalEndocrinology

Abstract

fetched live from OpenAlex

AIMS: Evidence is limited as to who benefit the most from sodium-glucose cotransporter 2 inhibitors (SGLT2i), especially among people without elevated cardiovascular disease (CVD) risk. To address this knowledge gap, we investigated the heterogeneity in the effect of SGLT2i across CVD risk profiles. METHODS AND RESULTS: Using a target trial emulation framework, we compared SGLT2i vs. dipeptidyl peptidase 4 inhibitors (DPP4i) in a nationwide insurer-based database of working-age Japanese citizens in 2015-23. The primary outcome was a composite of all-cause death, myocardial infarction, stroke, or heart failure over 3 years. Machine learning causal forest was applied to assess heterogeneity by predicting individual-level risk reduction in primary outcomes by SGLT2i and its correlation with CVD risk score. Overall, among 150 830 individuals included in this study (mean age, 54 years; female, 13.3%), SGLT2i was associated with decreased risk of primary outcomes {3-year risk difference, +0.38 [95% confidence interval (CI): 0.16-0.61] percentage points}. The causal forest model revealed heterogeneity in the effectiveness of SGLT2i, with estimated benefit correlating weakly with CVD risk score (r = 0.287, P < 0.001). In particular, among 107 425 individuals with low CVD risk, 97 757 (91.0%) were predicted to benefit from SGLT2i. This subpopulation was characterized as individuals with higher blood pressure, body mass index, and fasting plasma glucose levels even with low CVD risk score. CONCLUSION: The cardioprotective effect of SGLT2i was heterogeneous and more strongly predicted by individual patient characteristics than by overall CVD risk score, highlighting the importance of considering its benefit beyond the conventional risk stratification approach.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.062
Threshold uncertainty score0.516

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.242
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of Preventive CardiologySame topicDiabetes Treatment and ManagementFrench-language works237,207